PNC FINANCIAL SERVICES GROUP, INC.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 713676
Pittsburgh, PA
Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$14,082,131
+$682,472 QoQ
Shares Held
18,226
+5.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.85635904751453.ToString("F0")%
Shared 6.76506090200812.ToString("F0")%
None 0.37858005047734006.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $99,745,852 across 264 Biotechnology names. REGN ranks #2 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,942 | $32,124,978 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
18,226 | $14,082,131 | |
| 3 | TECH |
BIO-TECHNE Corp
|
93,722 | $4,897,909 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,322 | $4,076,976 | |
| 5 | MRNA |
Moderna, Inc.
|
69,883 | $3,550,054 | |
| 6 | INCY |
Incyte Corp
|
33,976 | $3,197,817 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
37,360 | $3,135,250 | |
| 8 | ARGX |
Argenx SE
|
3,796 | $2,772,027 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,082,131 | 18,226 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $13,399,659 | 17,360 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $9,736,265 | 17,316 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $7,725,375 | 14,715 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $10,123,573 | 15,962 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $11,908,017 | 16,717 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $19,263,968 | 18,325 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $19,099,314 | 18,172 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $17,967,759 | 18,668 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $15,985,752 | 18,201 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $15,060,163 | 18,300 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,491,305 | 18,776 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,054,606 | 19,539 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,271,066 | 19,780 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $14,343,648 | 20,822 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,792,051 | 21,640 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,768,226 | 22,577 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $14,753,567 | 23,362 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,520,811 | 10,775 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $6,375,730 | 11,415 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $5,278,345 | 11,156 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $6,269,800 | 12,978 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,964,546 | 14,228 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $10,171,729 | 16,310 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $7,154,422 | 14,652 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||